Morinamide

Morinamide
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J04AK04 (WHO) ;
Identifiers
	IUPAC name N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;
CAS Number	952-54-5;
PubChem CID	70374;
ChemSpider	63555;
UNII	8CFL28PA3W;
KEGG	D07248 ;
CompTox Dashboard (EPA)	DTXSID4046159 ;
ECHA InfoCard	100.012.237
Chemical and physical data
Formula	C10H14N4O2
Molar mass	222.248 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1COCCN1CNC(=O)C2=NC=CN=C2;
	InChI InChI=1S/C10H14N4O2/c15-10(9-7-11-1-2-12-9)13-8-14-3-5-16-6-4-14/h1-2,7H,3-6,8H2,(H,13,15); Key:GVTLAVKAVSKBKK-UHFFFAOYSA-N;

Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.^[1] It behaves as a prodrug for Pyrazinamide.

References[]

^ Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.

This antiinfective drug article is a stub. You can help Wikipedia by .

[pmid7761665-1] Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.

[1]